Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1973 Jul;4(1):37–43. doi: 10.1128/aac.4.1.37

Effect of Puromycin Analogues and Other Agents on Peptidyl-Puromycin Synthesis on Polyribosomes

Sidney Pestka 1,2, Robert Vince 1,2, Susan Daluge 1,2, Raymond Harris 1,2,1
PMCID: PMC444501  PMID: 4598844

Abstract

The incorporation of [3H]puromycin into nascent polypeptide chains of polyribosomes has proved to be a sensitive method of evaluating effects of inhibitors on peptide bond synthesis. Several analogues of puromycin were found to react with polyribosomes from both bacteria and rat liver. The Km for puromycin is 4 μM with bacterial polyribosomes; under the same conditions, the Ki for ψ-hydroxy-puromycin (6-dimethylamino-9-[3-(l-β-phenyllactylamino)-3-deoxy-β- d-ribofuranosyl] purine) is 240 μM and for a carbocyclic analogue of puromycin (6-dimethylamino-9- {R- [2R-hydroxy-3R- (p-methoxyphenyl-l-alanylamino)]-cyclopentyl}purine) is 1 μM. Both were found to be competitive inhibitors of puromycin. The Km for C-A-C-C-A(Phe) is 250 μM. In addition, the dissociation constant for C-A-C-C-A(Phe) binding to washed ribosomes was found to be 1 and 0.03 μM in the absence and presence, respectively, of 20% (vol/vol) ethanol. The results with these analogues lead to the following conclusions. Substitution of a hydroxyl group for the α-amino group of puromycin results in an active analogue with about one-sixtieth the affinity of puromycin in the reaction. Omission of the 5′-hydroxymethyl group or substitution of the furanosyl ring oxygen by a carbon atom in the carbocyclic analogue reduces its activity compared with puromycin only slightly. Additionally, the relatively high Km for C-A-C-C-A(Phe) as an acceptor compared with puromycin suggests the existence of a protective mechanism on polyribosomes, which prevents aminoacyl-transfer ribonucleic acid (tRNA) free in solution from stripping nascent chains from polyribosomes so that only aminoacyl-tRNA bound to ribosomes through the appropriate coding mechanism can form a peptide bond.

Full text

PDF
37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belleau B., Malek G. A new convenient reagent for peptide syntheses. J Am Chem Soc. 1968 Mar 13;90(6):1651–1652. doi: 10.1021/ja01008a045. [DOI] [PubMed] [Google Scholar]
  2. DIXON M. The determination of enzyme inhibitor constants. Biochem J. 1953 Aug;55(1):170–171. doi: 10.1042/bj0550170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Daluge S., Vince R. Synthesis and antimicrobial activity of a carbocyclic puromycin analog. 6-Dimethylamino-9-(R(2R-hydroxy-3R-(p-methoxyphenyl-L alanylamino))-cyclopentyl)purine. J Med Chem. 1972 Feb;15(2):171–177. doi: 10.1021/jm00272a012. [DOI] [PubMed] [Google Scholar]
  4. Fahnestock S., Neumann H., Shashoua V., Rich A. Ribosome-catalyzed ester formation. Biochemistry. 1970 Jun 9;9(12):2477–2483. doi: 10.1021/bi00814a013. [DOI] [PubMed] [Google Scholar]
  5. Harris R. J., Mercer J. F., Skingle D. C., Symons R. H. Substrates for ribosomal peptidyl transferase: synthesis of 3'-N-aminoacyl and 5'-O-nucleotidyl analogues of puromycin. Can J Biochem. 1972 Aug;50(8):918–926. doi: 10.1139/o72-128. [DOI] [PubMed] [Google Scholar]
  6. Harris R., Pestka S. Studies on the formation of transfer ribonucleic acid-ribosome complexes. XXIV. Effects of antibiotics on binding of aminoacyl-oligonucleotides to ribosomes. J Biol Chem. 1973 Feb 25;248(4):1168–1174. [PubMed] [Google Scholar]
  7. Lessard J. L., Pestka S. Studies on the formation of transfer ribonucleic acid-ribosome complexes. XXII. Binding of aminoacyl-oligonucleotides to ribosomes. J Biol Chem. 1972 Nov 10;247(21):6901–6908. [PubMed] [Google Scholar]
  8. Pestka S., Goorha R., Rosenfeld H., Neurath C., Hintikka H. Studies on transfer ribonucleic acid-ribosome complexes. XX. Peptidyl-puromycin synthesis on mammalian polyribosomes. J Biol Chem. 1972 Jul 10;247(13):4258–4263. [PubMed] [Google Scholar]
  9. Pestka S. Peptidyl-puromycin synthesis on polyribosomes from Escherichia coli. Proc Natl Acad Sci U S A. 1972 Mar;69(3):624–628. doi: 10.1073/pnas.69.3.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pestka S., Rosenfeld H., Harris R., Hintikka H. Studies on transfer ribonucleic acid-ribosome complexes. XXI. Effect of antibiotics on peptidyl-puromycin synthesis by mammalian polyribosomes. J Biol Chem. 1972 Nov 10;247(21):6895–6900. [PubMed] [Google Scholar]
  11. Pestka S. Studies on the formation of transfer ribonucleic acid-ribosome complexes. 8. Survey of the effect of antibiotics of N-acetyl-phenylalanyl-puromycin formation: possible mechanism of chloramphenicol action. Arch Biochem Biophys. 1970 Jan;136(1):80–88. doi: 10.1016/0003-9861(70)90329-2. [DOI] [PubMed] [Google Scholar]
  12. Pestka S. Studies on transfer ribonucleic acid-ribosome complexes. XIX. Effect of antibiotics on peptidyl puromycin synthesis on polyribosoms from Escherichia coli. J Biol Chem. 1972 Jul 25;247(14):4669–4678. [PubMed] [Google Scholar]
  13. Vince R., Daluge S., Palm M. Inhibition of in vitro protein synthesis by a carbocyclic puromycin analog. Biochem Biophys Res Commun. 1972 Jan 31;46(2):866–870. doi: 10.1016/s0006-291x(72)80221-3. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES